CCM
RPRX icon

Cutter Capital Management’s Royalty Pharma RPRX Stock Holding History

Cutter Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-356,894
Closed -$11.1M – 17
2025
Q1 		$11.1M Sell
356,894
-407,965
-53% -$12.9M 4.84% 11
2024
Q4 		$19.5M Buy
764,859
+100,000
+15% +$2.65M 8% 3
2024
Q3 		$18.8M Sell
664,859
-27,441
-4% -$760K 5.55% 3
2024
Q2 		$18.3M Buy
692,300
+280,760
+68% +$7.78M 5.51% 5
2024
Q1 		$12.5M Buy
411,540
+41,540
+11% +$1.22M 4.78% 7
2023
Q4 		$10.4M Buy
+370,000
New +$10.2M 4.97% 9

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return

Cutter Capital Management's RPRX Position: Q2 2025 in Review

Cutter Capital Management sold out of Royalty Pharma (RPRX) in Q2 2025, closing a stake of 356,894 shares — an estimated $11.1M sold.

Cutter Capital Management first reported a position in RPRX in Q4 2023 and held it in 6 quarters. The position peaked at $19.5M in Q4 2024. 455 funds tracked by Wall St. Rank hold RPRX as of Q2 2025.

  • Cutter Capital Management reported no remaining Royalty Pharma position as of Q2 2025 after selling out during the quarter.
  • Cutter Capital Management sold 356,894 Royalty Pharma shares in Q2 2025, an estimated $11.1M.
  • Cutter Capital Management first reported a position in Royalty Pharma in Q4 2023 and held it in 6 quarters.
  • Cutter Capital Management's Royalty Pharma position peaked at $19.5M in Q4 2024.
  • 455 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2025.

Based on Cutter Capital Management's 13F filing for Q2 2025.